Human Genome Sciences Rejects $2.59 Billion Offer From GlaxoSmithKline – New York Times
LONDON – The biotechnology company Human Genome Sciences rejected ... Human Genome Sciences has retained Goldman Sachs, Credit Suisse, and the law firms Skadden, Arps, Slate, Meagher & Flom and DLA Piper to help with its potential sale.
Subscribe to LegalLaw247.Com Newsletter